Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Hepatic encephalopathy post-TIPS: Current status and prospects in predictive assessment. Local targets link to admitted publications; unresolved targets remain external evidence.
Role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension: review and update of the literature
10.1016/j.cld.2019.07.004 · 2019 · External reference
North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension
10.1016/j.cgh.2021.07.018 · 2022 · External reference
Clearing the confusion over hepatic encephalopathy after tips creation: incidence, prognostic factors, and clinical outcomes
10.1007/s10620-014-3391-0 · 2015 · External reference
Cellular pathogenesis of hepatic encephalopathy: an update
10.3390/biom13020396 · 2023 · External reference
Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt according to its severity and temporal grading classification
10.1007/s11547-017-0770-6 · 2017 · External reference
Shunt-Induced Hepatic Encephalopathy in TIPS: Current Approaches and Clinical Challenges
10.3390/jcm9113784 · 2020 · External reference
TIPS: 25 years later
10.1016/j.jhep.2013.06.014 · 2013 · External reference
Diagnosis and management of hepatic encephalopathy: The French recommendations
10.1111/liv.15510 · 2023 · External reference
In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States From 2005 to 2009
10.1016/j.cgh.2012.05.016 · 2012 · External reference
EASL Clinical Practice Guidelines on the management of hepatic encephalopathy
10.1016/j.jhep.2022.06.001 · 2022 · External reference
Nationwide trends and predictors of inpatient mortality in 83884 transjugular intrahepatic portosystemic shunt
10.3748/wjg.v22.i25.5780 · 2016 · External reference
History of hepatic encephalopathy is not a contraindication to transjugular intrahepatic portosystemic shunt placement for refractory ascites
10.14309/ctg.0000000000000378 · 2021 · External reference
Prediction and risk factors for prognosis of cirrhotic patients with hepatic encephalopathy
10.1155/2021/5623601 · 2021 · External reference
ALBI grade: evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma
10.1016/j.jhepr.2021.100347 · 2021 · External reference
Current approaches to hepatic encephalopathy
10.1016/j.aohep.2022.100757 · 2022 · External reference
MELD 3.0: the model for end-stage liver disease updated for the modern era
10.1053/j.gastro.2021.08.050 · 2021 · External reference
Development and validation of prognostic models to estimate the risk of overt hepatic encephalopathy after tips creation: a multicenter study
10.14309/ctg.0000000000000461 · 2022 · External reference
Using machine learning methods to predict 28-day mortality in patients with hepatic encephalopathy
10.1186/s12876-023-02753-z · 2023 · External reference
Single-Centre Retrospective Training Cohort Using Artificial Intelligence for Prognostic Prediction of Encephalopathy, Mortality, and Liver Dysfunction after Early TIPS Creation
10.1007/s00270-021-02907-0 · 2021 · External reference
Radiomics-based classification models for HBV-related cirrhotic patients with covert hepatic encephalopathy
10.1002/brb3.1970 · 2021 · External reference
A radiomics model of liver CT to predict risk of hepatic encephalopathy secondary to hepatitis B related cirrhosis
10.1016/j.ejrad.2020.109201 · 2020 · External reference
CT-based radiomics model for preoperative prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt
10.1259/bjr.20210792 · 2022 · External reference
3D automatic liver and spleen assessment in predicting overt hepatic encephalopathy before TIPS: a multi-center study
10.1007/s12072-023-10570-5 · 2023 · External reference
Prevention and treatment of hepatic encephalopathy during the perioperative period of transjugular intrahepatic portosystemic shunt
10.4240/wjgs.v15.i8.1564 · 2023 · External reference
Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt: a multicentre randomised, double blind, placebo controlled trial
10.1136/bmjgast-2020-000531 · 2020 · External reference
Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt
10.3748/wjg.v27.i5.416 · 2021 · External reference
Prophylactic embolization of large spontaneous portosystemic shunts with transjugular intrahepatic portosystemic shunt: A panacea for post-TIPS hepatic encephalopathy?
10.1002/hep.32525 · 2022 · External reference
Transjugular intrahepatic portosystemic shunt through left branch versus right branch of portal vein: a meta-analysis
10.1007/s00261-020-02789-9 · 2021 · External reference
Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension
10.1136/gutjnl-2019-320221 · 2020 · External reference
Portal flow diversion based on portography is superior than puncture site in the prediction of overt hepatic encephalopathy after TIPS creation
10.1186/s12876-022-02447-y · 2022 · External reference
Hepatic Encephalopathy After TIPS Placement: Predictive Factors, Prevention Strategies, and Management
10.1007/s00270-021-03045-3 · 2022 · External reference
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
10.1016/j.jhep.2018.03.024 · 2018 · External reference
Incidence and Bedside Predictors of the First Episode of Overt Hepatic Encephalopathy in Patients With Cirrhosis
10.14309/ajg.0000000000000762 · 2020 · External reference
Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt
10.1016/j.cld.2011.12.008 · 2012 · External reference
10.1002/hep.27210
10.1002/hep.27210 · External reference
Prediction and prevention of the first episode of overt hepatic encephalopathy in patients with cirrhosis
10.1097/hc9.0000000000000096 · 2023 · External reference
Refractory Hepatic Encephalopathy After Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors and Outcomes with Revision
10.1007/s00270-018-1992-2 · 2018 · External reference
Review article: post-TIPSS hepatic encephalopathy—current knowledge and future perspectives
10.1111/apt.16825 · 2022 · External reference
The pathogenesis of gut microbiota in hepatic encephalopathy by the gut-liver-brain axis
10.1042/bsr20222524 · 2023 · External reference
Epidemiology of Hepatic Encephalopathy
10.1016/j.cld.2020.01.001 · 2020 · External reference
Risk Factors for Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt: Beyond Stent Diameter
10.1007/s10620-021-06868-9 · 2021 · External reference
Low adipose tissue index as an indicator of hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt
10.1007/s00261-023-03813-4 · 2023 · External reference
Hepatic encephalopathy
10.1038/s41572-022-00366-6 · 2022 · External reference
A nomogram to predict the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in Cirrhotic Patients
10.1038/s41598-020-65227-2 · 2020 · External reference
Predictors of Occurrence and Risk of Hepatic Encephalopathy After TIPS Creation: A 15-Year Experience
10.1007/s00270-020-02512-7 · 2020 · External reference
Diabetes mellitus-risk factor and potential future target for hepatic encephalopathy in patients with liver cirrhosis?
10.1007/s11011-022-01068-4 · 2023 · External reference
Socioeconomic Status Is Associated with the Risk of Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation
10.1016/j.jvir.2020.11.022 · 2021 · External reference
Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin
10.1007/s40273-018-0641-6 · 2018 · External reference
Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt
10.1016/j.clnu.2021.12.036 · 2022 · External reference
Clinical value of hemodynamic changes in diagnosis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt
2022 · External reference
Reduction of portosystemic gradient during transjugular intrahepatic portosystemic shunt achieves good outcome and reduces complications
10.3748/wjg.v29.i15.2336 · 2023 · External reference
Individualized portal pressure gradient threshold based on liver function categories in preventing rebleeding after TIPS
10.1007/s12072-023-10489-x · 2023 · External reference
A novel nomogram predicting overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in portal hypertension patients
10.1038/s41598-023-42061-w · 2023 · External reference
Ammonia predicts clinical outcomes in cirrhosis –but there are caveats to consider
10.1016/j.jhep.2023.07.023 · 2023 · External reference
Plasma ammonia levels predict hospitalisation with liver-related complications and mortality in clinically stable outpatients with cirrhosis
10.1016/j.jhep.2022.07.014 · 2022 · External reference
Ammonia and prognosis of cirrhosis: A new perspective for identifying high-risk patients
10.1016/j.jhep.2022.09.007 · 2023 · External reference
Optical System Based on Nafion Membrane for the Detection of Ammonia in Blood Serum Samples
10.3390/bios12121079 · 2022 · External reference
Mechanistic insight, diagnosis, and treatment of ammonia-induced hepatic encephalopathy
10.1111/jgh.14408 · 2019 · External reference
Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis
10.1016/j.jhep.2023.05.022 · 2023 · External reference
Changes of Plasma Blood Ammonia Levels of Chinese Healthy People and the Establishment of Reference Intervals
10.7754/clin.lab.2022.220105 · 2023 · External reference
Diagnosis and Treatment of Low-Grade Hepatic Encephalopathy
10.1159/000375350 · 2015 · External reference
Neuromodulatory role of L-arginine: nitric oxide precursor against thioacetamide-induced-hepatic encephalopathy in rats via downregulation of NF-κB-mediated apoptosis
10.1007/s11356-023-28184-7 · 2023 · External reference
10.1001/jama.2014.2398
10.1001/jama.2014.2398 · External reference
Long-Term Effects of Rifaximin on Patients with Hepatic Encephalopathy: Its Possible Effects on the Improvement in the Blood Ammonia Concentration Levels, Hepatic Spare Ability and Refractory Ascites
10.3390/medicina58091276 · 2022 · External reference
Elevated Ammonia Level as a Diagnostic Marker of Hepatic Encephalopathy
10.24079/cajms.2016.01.009 · 2016 · External reference
A Case of Perihilar Cholangiocarcinoma with Postoperative Hepatic Encephalopathy Due to Portosystemic Shunt Treated by Percutaneous Embolization
2023 · External reference
Chinese guidelines on management of hepatic encephalopathy in cirrhosis
10.3748/wjg.v25.i36.5403 · 2019 · External reference
Low Serum Cholinesterase Identifies Patients With Worse Outcome and Increased Mortality After TIPS
10.1002/hep4.1829 · 2022 · External reference
Clinical diagnostic significance of prealbumin, cholinesterase and retinol binding protein in liver cirrhosis combined with encephalopathy
10.1080/09674845.2018.1523673 · 2019 · External reference
The relationship between homoarginine and liver biomarkers: a combination of epidemiological and clinical studies
10.1038/s41598-023-32363-4 · 2023 · External reference
Concurrent Change in Serum Cholinesterase Activity and Midregional-Proadrennomedullin Level Could Predict Patient Outcome following Liver Transplantation
10.3390/biom12070989 · 2022 · External reference
Gamma-glutamyl transpeptidase to cholinesterase and platelet ratio in predicting significant liver fibrosis and cirrhosis of chronic hepatitis B
10.1016/j.cmi.2018.06.002 · 2019 · External reference
Raised serum Interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy
10.1111/apt.15515 · 2019 · External reference
Association of preoperative IL-6 levels with overt HE in patients with cirrhosis after TIPS
2023 · External reference
Evaluation of IL‐6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis
10.1002/hep4.1883 · 2022 · External reference
Transection of the oesophagus for bleeding oesophageal varices
10.1002/bjs.1800600817 · 1973 · External reference
Early transjugular intrahepatic portosystemic shunt for acute variceal bleeding: a systematic review and meta-analysis
10.1007/s00330-020-07525-x · 2021 · External reference
Prediction of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt treatment: a cohort study
10.1007/s12072-021-10188-5 · 2021 · External reference
Freiburg index of post-TIPS survival: The first score for individual prediction and a complementary tool for risk stratification
10.1016/j.jhep.2021.05.042 · 2021 · External reference
The combination of Child-Pugh score and quantitative CT-based spleen volume could predict the risk of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation
10.1007/s00261-021-02972-6 · 2021 · External reference
Preoperative prediction of overt hepatic encephalopathy caused by transjugular intrahepatic portosystemic shunt
10.1016/j.ejrad.2022.110384 · 2022 · External reference
Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival
10.1016/j.jhep.2021.01.023 · 2021 · External reference
Nutritional status in hepatic encephalopathy and transjugular intrahepatic portosystemic shunt – TIPS, and strategies to improve the outcomes
10.51821/86.2.11430 · 2023 · External reference
MELD 3.0 in Advanced Chronic Liver Disease
10.1146/annurev-med-051322-122539 · 2024 · External reference
Risk factors for overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation in patients with liver cirrhosis
10.1111/1751-2980.12957 · 2021 · External reference
Application of the model for end-stage liver disease score for transjugular intrahepatic portosystemic shunt in cirrhotic patients with refractory ascites and renal impairment
10.1097/00042737-200406000-00015 · 2004 · External reference
Changes in Kidney Function After Transjugular Intrahepatic Portosystemic Shunts Versus Large-Volume Paracentesis in Cirrhosis: A Matched Cohort Analysis
10.1053/j.ajkd.2016.02.041 · 2016 · External reference
Effect of transjugular intrahepatic portosystemic shunt placement on renal function: a 7-year, single-center experience
10.1016/j.jvir.2010.05.009 · 2010 · External reference
Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis
10.3748/wjg.v29.i32.4873 · 2023 · External reference
Newly Proposed ALBI Grade and ALBI-T Score as Tools for Assessment of Hepatic Function and Prognosis in Hepatocellular Carcinoma Patients
10.1159/000494844 · 2019 · External reference
The ALBI score: From liver function in patients with HCC to a general measure of liver function
10.1016/j.jhepr.2022.100557 · 2022 · External reference
Albumin-Bilirubin as an accurate and simple prognostic score for chronic hepatitis B-related liver cirrhosis
10.1016/j.dld.2019.01.011 · 2019 · External reference
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
10.1200/jco.2014.57.9151 · 2015 · External reference
Prediction of Patient Hepatic Encephalopathy Risk with Freiburg Index of Post-TIPS Survival Score Following Transjugular Intrahepatic Portosystemic Shunts: A Retrospective Study
10.2147/ijgm.s359918 · 2022 · External reference
Dynamic assessments of hepatic encephalopathy and ammonia levels predict mortality in acute-on-chronic liver failure
10.1007/s12072-021-10221-7 · 2021 · External reference
Customer churn prediction using composite deep learning technique
10.1038/s41598-023-44396-w · 2023 · External reference
Portosystemic shunt placement reveals blood signatures for the development of hepatic encephalopathy through mass spectrometry
10.1038/s41467-023-40741-9 · 2023 · External reference
Construction of prediction model of cirrhosis-related hepatic encephalopathy based on machine learning algorithm
2021 · External reference
The role of artificial intelligence in hepatology research and practice
10.1097/mog.0000000000000926 · 2023 · External reference
Artificial intelligence in medicine: revolutionizing healthcare for improved patient outcomes
10.32892/jmri.292 · 2023 · External reference
User Preferences for AI-based Healthcare Apps: an Association Mining Analysis
10.1007/s42979-024-02739-y · 2024 · External reference
Hepatic encephalopathy: Diagnosis and management
10.1111/liv.13752 · 2018 · External reference
Retracted] Risk Factor Analysis of Hepatic Encephalopathy and the Establishment of Diagnostic Model
10.1155/2022/3475325 · 2022 · External reference
A review of Explainable Artificial Intelligence in healthcare
10.1016/j.compeleceng.2024.109370 · 2024 · External reference
Critical Appraisal of Artificial Intelligence-Enabled Imaging Tools Using the Levels of Evidence System
10.3174/ajnr.a7850 · 2023 · External reference
Regulatory considerations for medical imaging AI/ML devices in the United States: concepts and challenges
10.1117/1.jmi.10.5.051804 · 2023 · External reference
Strategic applications of artificial intelligence in healthcare and medicine
10.32996/jmhs.2023.4.3.8 · 2023 · External reference
Predictive Modeling in Medicine
10.3390/encyclopedia3020042 · 2023 · External reference
Preserving privacy in domain transfer of medical AI models comes at no performance costs: The integral role of differential privacy
2024 · External reference
Artificial intelligence in medicine: are we ready?
2023 · External reference
A simple covert hepatic encephalopathy screening model based on blood biochemical parameters in patients with cirrhosis
10.1371/journal.pone.0277829 · 2022 · External reference
Radiographical findings in patients with liver cirrhosis and hepatic encephalopathy
10.1093/gastro/gov049 · 2016 · External reference
Prediction of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Based on CT Radiomic Features of Visceral Adipose Tissue
10.1016/j.acra.2023.10.013 · 2023 · External reference
Relative Sarcopenia With Excess Adiposity Predicts Survival After Transjugular Intrahepatic Portosystemic Shunt Creation
10.2214/ajr.19.21655 · 2020 · External reference
Psoas Muscle Density Predicts Occurrences of Hepatic Encephalopathy in Patients Receiving Transjugular Intrahepatic Portosystemic Shunts within 1 year
10.1007/s00270-021-02961-8 · 2022 · External reference
Machine Learning Insights: Predicting Hepatic Encephalopathy After TIPS Placement
10.1007/s00270-023-03593-w · 2023 · External reference
From blackbox to explainable AI in healthcare: existing tools and case studies
2022 · External reference
An interpretable machine learning model for diagnosis of Alzheimer's disease
10.7717/peerj.6543 · 2019 · External reference
Causability and explainability of artificial intelligence in medicine
2019 · External reference
Applications of Explainable Artificial Intelligence in Diagnosis and Surgery
2022 · External reference
Explainable AI for retinoblastoma diagnosis: interpreting deep learning models with LIME and SHAP
10.3390/diagnostics13111932 · 2023 · External reference
Artificial intelligence (AI) systems for interpreting complex medical datasets
10.1002/cpt.650 · 2017 · External reference
10.1001/jamainternmed.2018.3763
10.1001/jamainternmed.2018.3763 · External reference
A novel decentralized federated learning approach to train on globally distributed, poor quality, and protected private medical data
10.1038/s41598-022-12833-x · 2022 · External reference
Model verification tools: a computational framework for verification assessment of mechanistic agent-based models
10.1186/s12859-022-04684-0 · 2021 · External reference
Shortcut learning in medical AI hinders generalization: method for estimating AI model generalization without external data
10.1038/s41746-024-01118-4 · 2024 · External reference
A framework for validating AI in precision medicine: considerations from the European ITFoC consortium
10.1186/s12911-021-01634-3 · 2021 · External reference
arXiv preprint
2024 · External reference
Lung cancer nodules detection via an adaptive boosting algorithm based on self‐normalized multiview convolutional neural network
10.1155/2022/5682451 · 2022 · External reference
Evaluation of large language models as a diagnostic aid for complex medical cases
10.3389/fmed.2024.1380148 · 2024 · External reference
10.3390/ijerph20043378
10.3390/ijerph20043378 · External reference
10.1001/jama.2023.8288
10.1001/jama.2023.8288 · External reference
The application of large language models in medicine: A scoping review
10.1016/j.isci.2024.109713 · 2024 · External reference
Unresolved reference
External reference
10.1002/aisy.202400304
10.1002/aisy.202400304 · External reference
Unresolved reference
External reference
Uncertainty quantification in multivariable regression for material property prediction with Bayesian neural networks
10.1038/s41598-024-61189-x · 2024 · External reference
Quantitative investigation of inappropriate regression model construction and the importance of medical statistics experts in observational medical research: a cross-sectional study
10.1136/bmjopen-2017-021129 · 2018 · External reference
A Bayesian mixture model for predicting the COVID-19 related mortality in the United States
10.4269/ajtmh.20-1147 · 2021 · External reference
10.1016/j.compbiomed.2023.107596
10.1016/j.compbiomed.2023.107596 · External reference
Gene function and cell surface protein association analysis based on single-cell multiomics data
10.1016/j.compbiomed.2023.106733 · 2023 · External reference
Development and validation of an interpretable radiomic nomogram for severe radiation proctitis prediction in postoperative cervical cancer patients
10.3389/fmicb.2022.1090770 · 2022 · External reference
Measuring depression severity based on facial expression and body movement using deep convolutional neural network
10.3389/fpsyt.2022.1017064 · 2022 · External reference
Development and Validation of a Deep Learning System for Staging Liver Fibrosis by Using Contrast Agent-enhanced CT Images in the Liver
10.1148/radiol.2018180763 · 2018 · External reference
Development and validation of radiomics model built by incorporating machine learning for identifying liver fibrosis and early-stage cirrhosis
10.1097/cm9.0000000000001113 · 2020 · External reference
Revolutionizing Infection Risk Scoring: An Ensemble "From Weak to Strong" Deduction Strategy and Enhanced Point-of-Care Testing Tools
10.1002/aisy.202300224 · 2023 · External reference
Modeling and analyzing single-cell multimodal data with deep parametric inference
10.1093/bib/bbad005 · 2023 · External reference
Novel microfluidic device for measurable residual disease detection in acute leukemia
2023 · External reference
10.1038/s41591-018-0316-z
10.1038/s41591-018-0316-z · External reference
A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH
10.1002/hep.31750 · 2021 · External reference
Artificial Intelligence in NASH Histology: Human Teaches a Machine for the Machine to Help Humans
10.1002/hep.31777 · 2021 · External reference
High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease
10.1016/j.cgh.2019.12.025 · 2020 · External reference
Artificial neural network-based models used for predicting 28- and 90-day mortality of patients with hepatitis B-associated acute-on-chronic liver failure
10.1186/s12876-020-01191-5 · 2020 · External reference
Automated Measurements of Muscle Mass Using Deep Learning Can Predict Clinical Outcomes in Patients With Liver Disease
10.14309/ajg.0000000000000662 · 2020 · External reference
How Does ChatGPT Perform on the United States Medical Licensing Examination? The Implications of Large Language Models for Medical Education and Knowledge Assessment
10.2196/45312 · 2023 · External reference
Overview of Chatbots with special emphasis on artificial intelligence-enabled ChatGPT in medical science
10.3389/frai.2023.1237704 · 2023 · External reference
Novel research and future prospects of artificial intelligence in cancer diagnosis and treatment
10.1186/s13045-023-01514-5 · 2023 · External reference
Unresolved reference
External reference
Large language models for structured reporting in radiology: performance of GPT-4, ChatGPT-3.5, Perplexity and Bing
10.1007/s11547-023-01651-4 · 2023 · External reference
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
10.1053/he.2000.5852 · 2000 · External reference
